Alector Stock Surges on Upgrade, AL101 Interim Data Crucial for Future Growth

miércoles, 11 de marzo de 2026, 11:39 am ET1 min de lectura
ALEC--

Alector stock surged after a BTIG upgrade to Buy from Neutral, citing the company's strategic pivot towards Alzheimer's disease treatment with its AL101 program. The firm's confidence in Alector's potential is high, but the company's interim data for AL101 will be crucial in determining the stock's future performance.

Alector Stock Surges on Upgrade, AL101 Interim Data Crucial for Future Growth

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios